The present invention involves the novel use of various classes of drugs, such as H.sub.2 and H.sub.3 agonists, as erectogenic agents in the treatment of male and female sexual dysfunction.
A method of treating sexual dysfunction comprising administering a therapeutically effective amount of a combination of phentolamine and apomorphine, as well as pharmaceutical compositions and kits useful in those methods, are disclosed.
There is disclosed herein a single use syringe (1) having a container section (2), a valve section (4) and a hollow needle (4a). The valve section (4) contains a one-way valve (40) which allows fluid to flow in only one direction through the valve section (4). The single use syringe (1) may also be provided with locking means to prevent the separation of the container section (2) from the valve section (4). There is also disclosed herein packaging (16, 17) and a carry case (10, 11) in which to store and transport the single use syringe (1).
A method of treating and a composition for treating female sexual arousal dysfunction, comprising administering to the patient a unit dose of a formulation comprising an effective amount of a prostaglandin, selected from prostaglandin E.sub.1, prostaglandin E.sub.2, pharmaceutically acceptable salts thereof and physiologically acceptable esters thereof, wherein the prostaglandin is formulated with prostaglandin F.sub.2.alpha., together with a pharmaceutically acceptable delivery medium and/or a lubricant.
Described is the use in the treatment of either male or female sexual dysfunction of selective antagonists of the .alpha..sub.1B -adrenergic receptor and the pharmaceutical compositions containing them as compounds capable of helping the sexual act avoiding at the same time excessive side effects due to acute hypotension.
A method of treating female arousal disorder (FAD) in a female patient is disclosed. The method includes orally administering an agent that inhibits cyclic guanosine 3'5'-monophosphate specific phosphodiesterase type 5 to the female patient.
